Apmonia Therapeutics logo

Apmonia Therapeutics

Developer of peptide-based biotechnology designed to provide therapeutic strategies for multiple types of cancer. The company focuses on creating drugs to treat glioblastoma, ovarian, colorectal, and ...

Healthcare
Reims, France
Founded 2019
15 employees
Website
Valuation
$26.8M
Latest known
Share Price
N/A
Total Raised
$12.1M
Last Round
N/A